Doxorubicin and Dose-Escalated Cyclophosphamide with Granulocyte Colony-Stimulating Factor for the Treatment of Hormone-Resistant Prostate Cancer
Antineoplastic Combined Chemotherapy Protocols
Granulocyte Colony-Stimulating Factor
This is a well-tolerated, active regimen for the treatment of HRPC. Toxicity was not different in patients with prior pelvic XRT, although these patients had a lower MTD.
Additional Document Info
has global citation frequency